Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids

被引:41
|
作者
O'Brien, Melissa
McDougall, Jason J. [1 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, 5850 Coll St, Halifax, NS B3H 4R2, Canada
关键词
MANAGEMENT; PF-04457845; INHIBITOR; EFFICACY; SAFETY;
D O I
10.1016/j.coph.2018.03.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cannabis has been used for millennia to treat a multitude of medical conditions including chronic pain. Osteoarthritis (OA) pain is one of the most common types of pain and patients often turn to medical cannabis to manage their symptoms. While the majority of these reports are anecdotal, there is a growing body of scientific evidence which supports the analgesic potential of cannabinoids to treat OA pain. OA pain manifests as a combination of inflammatory, nociceptive, and neuropathic pain, each requiring modality-specific analgesics. The body's innate endocannabinoid system (ECS) has been shown to ameliorate all of these pain subtypes. This review summarizes the components of the ECS and details the latest research pertaining to plant-based and man-made cannabinoids for the treatment of OA pain. Recent pre-clinical evidence supporting a role for the ECS to control OA pain is described as well as current clinical evidence of the efficacy of cannabinoids for treating OA pain in mixed patient populations.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 50 条
  • [21] Structural correlates of pain in joints with osteoarthritis
    Hunter, D. J.
    Guermazi, A.
    Roemer, F.
    Zhang, Y.
    Neogi, T.
    OSTEOARTHRITIS AND CARTILAGE, 2013, 21 (09) : 1170 - 1178
  • [22] Cannabinoids for pain management; a panacea or a plight? An overview of the current evidence as used for the forthcoming ANZCA Acute Pain Management: Scientific Evidence Book
    Emery, Paul
    Keogh, Peter
    ANESTHESIA AND ANALGESIA, 2021, 133 (3S_SUPPL): : 30 - 30
  • [23] Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits
    Hoch, E.
    Volkow, N. D.
    Friemel, C. M.
    Lorenzetti, V.
    Freeman, T. P.
    Hall, W.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2025, 275 (02) : 281 - 292
  • [24] MEDICINAL USE OF CANNABIS AND CANNABINOIDS IN OLDER ADULTS: WHERE IS THE EVIDENCE?
    Ahmed, Amir I. A.
    van den Elsen, Geke A. H.
    van der Marck, Marjolein A.
    Rikkert, Marcel G. M. Olde
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 (02) : 410 - 411
  • [25] The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review
    Cohen, Koby
    Weinstein, Aviv
    BRAIN SCIENCES, 2018, 8 (03)
  • [26] Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans
    Wolfgang, Aaron S.
    Hoge, Charles W.
    JAMA PSYCHIATRY, 2023, 80 (09) : 869 - 870
  • [27] Cannabinoids for the treatment of neuropathic pain: Clinical evidence
    Ashton, John C.
    Milligan, Erin D.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (01) : 65 - 75
  • [28] Cannabinoids and Pain for the Plastic Surgeon What Is the Evidence?
    Stephens, Kristen L.
    Heineman, John T.
    Forster, Grace L.
    Timko, Michael P.
    DeGeorge, Brent R., Jr.
    ANNALS OF PLASTIC SURGERY, 2022, 88 (05) : S508 - S511
  • [29] Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology
    Turgeman, Ilit
    Bar-Sela, Gil
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (03) : 285 - 296
  • [30] Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials
    Fisher, Emma
    Moore, R. Andrew
    Fogarty, Alexandra E.
    Finn, David P.
    Finnerup, Nanna B.
    Gilron, Ian
    Haroutounian, Simon
    Krane, Elliot
    Rice, Andrew S. C.
    Rowbotham, Michael
    Wallace, Mark
    Eccleston, Christopher
    PAIN, 2021, 162 : S45 - S66